The White House pulled Heidi Overton's nomination to lead the Food and Drug Administration (FDA) on Tuesday, a day before a Senate committee vote she appeared unlikely to win, after Republican senators and the president's own health movement allies pushed back.
The decision ended months of doubt over a pick that struggled from the start. Republicans hold a one-seat edge on the Senate Health, Education, Labor and Pensions Committee, so a single defection could have blocked her from reaching the full Senate. Officials who worked on the nomination had grown uneasy about her support after this month's midterm losses, according to people familiar with the matter who spoke to Reuters.